18.09.2026 Sanlam Writes Down AfroCentric to Nil but Won’t Sell Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business. This article is for Health Matters subscribers Subscribers read every article in full, receive the daily briefing and have access to the complete archive. SubscribeLog in Afrocentric, Bonitas, healthcare, Medical Scheme Administration, Medscheme, Sanlam